Biotech Archives - Page 16 of 75 - Boston Life Sciences Times

Vyome Appoints Dr. Aditya Bardia as Senior Medical Advisor to Guide Development of MFW Program

November 25, 2025

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

November 14, 2025

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

November 13, 2025

THIS WEEK'S STORIES

Inflammasome Therapeutics Completes Enrollment of Phase II Study for Dual Inflammasome Inhibitor K8 to Treat Geographic Atrophy

November 25, 2025

Sarepta Updates Clinical Progress for SRP-1003 in Myotonic Dystrophy Type 1

November 24, 2025

MindImmune Extends Series A to $30 Million to Advance Alzheimer’s Therapy and Names Isaac Stoner as CEO

November 24, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

Galux Reports AI Engine Produced High-Affinity Antibodies From Only 50 Designs

Enveric Biosciences Gains Fourth Notice of Allowance for EVM401 Drug Candidate Series

Enigma Biomedical USA Awarded Grant From The Michael J. Fox Foundation to Advance Novel α-Synuclein PET Imaging Biomarker

Inflammasome Therapeutics Completes Enrollment of Phase II Study for Dual Inflammasome Inhibitor K8 to Treat Geographic Atrophy

Sarepta Updates Clinical Progress for SRP-1003 in Myotonic Dystrophy Type 1

Most Read

GE HealthCare Receives FDA Authorization for Deep-Learning Mammography Reconstruction Tool

Otsuka’s VOYXACT Wins FDA Accelerated Approval for IgA Nephropathy Proteinuria Reduction

Galux Reports AI Engine Produced High-Affinity Antibodies From Only 50 Designs

EdgeOne Medical Hires Industry Veteran Marty Shelton as Chief Operating Officer

EDITOR PICKS

Vyome Appoints Dr. Aditya Bardia as Senior Medical Advisor to Guide Development of MFW Program

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

THIS WEEK'S STORIES

Inflammasome Therapeutics Completes Enrollment of Phase II Study for Dual Inflammasome Inhibitor K8 to Treat Geographic Atrophy

Sarepta Updates Clinical Progress for SRP-1003 in Myotonic Dystrophy Type 1

MindImmune Extends Series A to $30 Million to Advance Alzheimer’s Therapy and Names Isaac Stoner as CEO

POPULAR CATEGORY

ABOUT US

FOLLOW US